TP53 and breast cancer: Moreover, our research group has reported that low concentrations of rosiglitazone and the RXR ligand 9-cis-retinoic acid (9RA) induce the intrinsic apoptotic pathway in breast cancer cells through both dependent or independent p53 transcriptional activity [44,45].